Key statistics
As of last trade, Abcellera Biologics Inc (ABCL:NSQ) traded at 2.59, 10.88% above the 52 week low of 2.34 set on Sep 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.49 |
---|---|
High | 2.60 |
Low | 2.49 |
Bid | 2.58 |
Offer | 2.59 |
Previous close | 2.50 |
Average volume | 1.48m |
---|---|
Shares outstanding | 294.67m |
Free float | 211.96m |
P/E (TTM) | -- |
Market cap | 736.66m USD |
EPS (TTM) | -0.5254 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 17:09 BST.
More ▼
Press releases
- AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024
- AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024
- AbCellera to Present at Upcoming Investor Conferences in September
- AbCellera Reports Q2 2024 Business Results
- AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines
More ▼